cdc-rfa-ck15-1505rev.pdf

Centers for Disease Control and Prevention

National Center for Emerging and Zoonotic Infectious Diseases

World Health Organization: Addressing Ebola and other Highly Infectious Diseases Internationally

CDC-RFA-CK15-1505

Application Due Date: 05/29/2015

Signature Date

World Health Organization: Addressing Ebola and other Highly Infectious Diseases Internationally

CDC-RFA-CK15-1505

TABLE OF CONTENTS

Overview Information

Federal Agency NameA.

Funding Opportunity TitleB.

Announcement TypeC.

Agency Funding Opportunity NumberD.

Catalog of Federal Domestic Assistance (CFDA) NumberE.

Dates

Letter of Intent Deadline1.

Application Deadline2.

Informational Conference Call for Potential Applicants3.

F.

Executive Summary

Summary Paragraph1.

G.

I.

Full Text

Funding Opportunity Description

Background 1.

CDC Project Description 2.

A.

Award Information

Funding Instrument Type 1.

Funding Activity Category 2.

Fiscal Year 3.

Approximate Total Fiscal Year Funding 4.

Approximate Project Period Funding 5.

Total Project Period Length 6.

Expected Number of Awards 7.

Approximate Average Award 8.

Award Ceiling 9.

Award Floor 10.

Estimated Award Date 11.

Budget Period Length 12.

Funds Tracking 13.

Direct Assistance 14.

Indirect Costs 15.

B.

Eligibility Information

Eligible Applicants 1.

Additional Information on Eligibility 2.

Justification for Less than Maximum Competition 3.

Other 4.

Cost Sharing or Matching 5.

Maintenance of Effort 6.

C.

Application and Submission Information D.

II.

Required Registrations 1.

Request Application Package 2.

Application Package 3.

Submission Dates & Times 4.

CDC Assurances and Certifications 5.

Content and Form of Application Submission 6.

Letter of Intent 7.

Table of Contents 8.

Project Abstract Summary 9.

Project Narrative 10.

Work Plan 11.

Budget Narrative 12.

Tobacco and Nutrition Policies 13.

Intergovernmental Review of Federal Programs 14.

Funding Restrictions 15.

Other Submission Requirements 16.

Application Review Information

Review and Selection Process 1.

Anticipated Announcement and Award Dates 2.

E.

Award Administration Information

Award Notices 1.

Administrative and National Policy Requirements 2.

Reporting 3.

Federal Funding Accountability and Transparency Act of 2006

4.

F.

Agency Contacts G.

Other Information H.

Glossary I.

Part I. Overview Information A. Federal Agency Name:

B. Funding Opportunity Title:

World Health Organization: Addressing Ebola and other Highly Infectious Diseases Internationally C. Announcement Type:

D. Agency Funding Opportunity Number:

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.818 F. Dates:

N/A 05/29/2015 N/A

1. Summary Paragraph:

a. Eligible Applicants: single-source

b. FOA Type: cooperative agreement

c. Approximate Number of Awards: 1

d. Total Project Period Funding: Up to approximately $100,000,000

e. Average One Year Award Amount: Up to approximately $100,000,000

f. Number of Years of Award: 3

g. Approximate Date When Awards will be Announced: Within 30 days of receipt of individual supplemental applications.

h. Cost Sharing and /or Matching Requirement: None

This FOA is a companion to the existing CDC-WHO cooperative agreement FOA#CK14-1402:

"Addressing Emerging Infectious Diseases and the International Health Regulations." This FOA is to specifically address the ongoing Ebola public health emergency and related needs internationally, including infrastructure and capacity building for highly infectious diseases in general.

Due to the rapid evolution of the Ebola outbreak with ever-changing needs, potentially unknown future needs, unique situations in each affected country, and the need for rapid and flexible support, WHO may submit 1 or more separate applications for projects over the term of the 36-month project period, See FOA Section D. - Application and Submission Information, Paragraph 4. - Submission Dates and Times for additional information.

Part II. Full Text A. Funding Opportunity Description

Centers for Disease Control and Prevention

This announcement is only for non-research international activities supported by CDC. If research is proposed, the application will not be considered. Research for this purpose is defined at:

http://www.cdc.gov /od /science /integrity /docs /cdc -policy -distinguishing -public -health -research -nonresearch.pdf.

CDC-RFA-CK15-1505

93.099 Additional CFDA Number:

1. Due Date for Letter of Intent:

2. Due Date for Applications:

3. Date for Informational Conference Call:

G. Executive Summary:

http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

1. Background

In March of 2014, the largest Ebola outbreak under record erupted in West Africa. Unlike many smaller preceding outbreaks of Ebola Virus, this particular outbreak spread to multiple African countries and caused (as of April 7, 2015) over 25,000 suspected human cases and over 10,000 deaths; the outbreak continues.

This outbreak has truly demonstrated that in the modern world of travel, trade and migration, infectious diseases do not respect geopolitical boundaries. With the ongoing Ebola outbreak in West Africa, this FOA serves to support and engage WHO to address Ebola and other highly infectious diseases in West Africa and elsewhere, internationally. The primary goal or first phase of this effort is "Getting to Zero" in West Africa;

that is, stopping transmission so there are no new cases identified. The next phase then is "Staying at Zero," or strengthening public health capacity so that future transmission/cases are averted. Surveillance, epidemiological tracking, specimen and patient handling, laboratory testing, infection control, emergency preparedness and response, and other public health activities, etc., all must be strengthened in Africa and globally to:

Assure rapid detection and response and safe handling of patients or specimens suspected of being infected with Ebola or other highly infectious diseases/agents Strengthen WHO emergency and preparedness and response capabilities Strengthen and fill gaps in ongoing non-Ebola public health infrastructure and programs (e.g., vaccination campaigns, routine public health activities, etc.) that are being challenged and in some instances, stalled, due to the ongoing Ebola outbreak.

a. Statutory Authorities

This program is authorized under sections 301 and 307 of the Public Health Service Act, as amended [42 U.S.C. §§ 241 and2421].

b. Healthy People 2020

This program addresses the Health People 2020 goal: Immunization and Infectious Diseases. For more information, go to www.healthypeople.gov

c. Other National Public Health Priorities and Strategies

N/A

d. Relevant Work

This FOA builds upon the ongoing work, infrastructure, and collaborations between CDC and WHO, including under cooperative agreement FOA# CDC-RFA-CK-14-1402: World Health Organization: Addressing Emerging Infectious Diseases and the International Health Regulations. For decades, CDC and WHO have collaborated to address global capacity to identify, respond, and prevent infectious diseases. WHO has established offices in most countries around the world, including the countries of West Africa. Since March 2014, WHO has been working side-by-side with country health officials and CDC and many other organizations to battle the ongoing Ebola outbreak. WHO and others have accomplished much but there is still much to do to stop the outbreak.

2. CDC Project Description

A.2.a. Approach

Strategies and Activities Short-Term Outcomes Long-Term Outcomes http://www.healthypeople.gov/ http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

Intensify active surveillance, case finding, contact tracing, monitoring, etc., at local levels

Strengthen capabilites for epidemiologic and laboratory analysis and program evaluation.

Intensify social mobilization, community education and engagement, and psychosocial care for infected persons and their families

Improve Ebola case management and infection control

Strengthen epidemiology and program evaluation capabilities

Strengthen non-Ebola public health activities that are impacted by the Ebola outbreak

Increase security and logistics for local responders

Strengthen WHO emergency preparedness and response capability

Increased and more rapid identification of new Ebola cases in affected countries*

Increased community knowledge and support for Ebola response and prevention efforts*

Reduced transmission in clinical and community settings*

Reinvigorated non-Ebola public health activities that have been interrupted or slowed due to the Ebola outbreak*

More coordinated and robust emergency preparedness and response capabilities*

Reduced number of new Ebola cases leading to the end of the outbreak ("Getting to and Staying at Zero Cases")

Prevention of spread of the Ebola outbreak into other countries

Improved preparedness for potential future outbreaks of Ebola or other highly infectious diseases

i. Problem Statement

This FOA addresses the ongoing Ebola international public health emergency and the underlying public health infrastructure and capability gaps in affected countries and globally. The aim is to 1) stop the current outbreak and 2) strengthen global capacity and preparedness to monitor ebola and other highly infectious diseases and respond to future outbreaks.

ii. Purpose

With the overall intent of breaking the chain of transmission of the ongoing Ebola outbreak in West Africa, this FOA supports WHO specifically to address the Ebola outbreak and the underlying public health capacity gaps, as well as to address the outbreak's impact on other non-Ebola public health activities. Surveillance, epidemiological tracking, specimen and patient handling, laboratory testing, infection control, emergency preparedness and response, etc., all must be strengthened in Africa and globally to assure rapid detection and response and safe handling of patients/speciments suspected of being infected with Ebola or other highly infectious diseases/agents, as well as to strengthen ongoing public health infrastructure and programs (e.g., vaccination campaigns, etc.) that are being challenged and in some instances, stalled, due to the Ebola outbreak.

iii. Outcomes

Rapidly identify Ebola cases in Guinea, Sierra Leone, and Liberia (and other countries should the outbreak spread beyond these three).

Increase community awareness, knowledge, and support for local Ebola response and prevention efforts.

Reduce Ebola transmission in clinical and community settings.

Reinvigorated non-Ebola public health activities that have been interrupted or slowed due to the Ebola http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

Reinvigorated non-Ebola public health activities that have been interrupted or slowed due to the Ebola outbreak.

More coordinated and robust WHO emergency preparedness and response capabilities.

iv. Funding Strategy

N/A

v. Strategies and Activities

At WHO and in regions and countries affected or threatened by the Ebola outbreak, strengthen capacity for Ebola preparedness and response nationally and at the local level:

Intensify active surveillance, case finding, contact tracing, monitoring, etc., at local levels

Conduct and improve ongoing active surveillance, with laboratory confirmation to ensure rapid identification of missed, new. or newly imported cases of Ebola.

Strengthen capacity for general surveillance including support for personnel required for surveillance and epidemiology activities.

Strengthen surveillance at entry points (border posts, airports and maritime ports) from countries with ongoing transmission of Ebola.

Strengthen capabilites for epidemiologic and laboratory analysis and program evaluation

Improve operational and technical analysis, coordination and monitoring of interventions.

Assess the impact of the epidemic on health care seeking and health care provision.

Intensify social mobilization, community and professional education and engagement, and psychosocial care for infected persons and their families

Conduct intensified social mobilization and community engagement to enhance awareness and gather community support, acceptance and participation in implementation of the containment measures Provide psychosocial first aid training for community agents and their supervisors so they can provide direct psychosocial support to contact cases and their families.

Develop and conduct communications to enforce the theme of "Staying at Zero Cases."

Develop and disseminate key Ebola health risk communication messages.

Improve Ebola case management and infection control

Develop plans for patient management as Ebola treatment units/centers are de-commissioned.

Improve infection control practices, particularly in facilities that might receive Ebola patients, for example, on a border wtih a country with ongoing transmission of Ebola

Strengthen non-Ebola public health activities that are impacted by the Ebola outbreak

Restore priority aspects of the health/public health system such as surveillance and assessment of vaccination coverage for epidemic-prone disease (e.g., measles), that are negatively impacted or stalled due to the Ebola outbreak.

Increase security and logistics for local responders

Strengthen field security to ensure operational security, and protect national and international staff involved in the response;

Strengthen WHO capabilities for preparedness and response to Ebola and other highly infectious diseases

Develop/implement WHO-led partnership mechanisms for a more robust and responsive global health emergency workforce.

Train frontline responders on emerging infectious diseases.

Strengthen critical International Health Regulations (IHR) and health systems capacities in Africa and http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf elsewhere.

1. Collaborations

a. With CDC-funded programs:

CDC Ebola Incident Command leadership and staff (required) CDC staff in affected countries specifically to address the Ebola outbreak (required) Established CDC programs in country (for example, Global HIV/AIDS Programs, Measles, Malaria, etc.) (required as necessary to assure coordinated efforts for addressing Ebola as well as assuring non-Ebola public health activities are not negatively impacted by the Ebola outbreak).

Center for Global Health, Global Health Security (required)

b. With organizations external to CDC:

Ministries of Health (required) Local country officials (required) USAID (required) Other U.S. governmental (USG) and non-USG organizations responding to the Ebola outbreak and/or that would respond to future emergencies (required as necessary depending on their involvement/role in various activities)

2. Target Populations

N/A

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy

CDC and WHO will jointly develop formal performance measures shortly after award. Following are outlines of potential measures that may be considered depending on the activities proposed:

Process Measures for Strategies and Activities:

Intensify active surveillance, case finding, contact tracing, monitoring, etc., at local levels

Number of people identified as having had contact with possibly infected individual(s) Number of people that have come in contact with possibly infected individual(s) that are monitored for symptoms for 21 days Number of reported, suspected and refered/transferred cases Number of cross-border cases intercepted at the border

Strengthen capabilites for epidemiologic and laboratory analysis and program evaluation.

Number of community deaths investigated Number of potential interventions evaluated Total number of samples analyzed Description of the impact of the epidemic on health care seeking and health care provision

Intensify social mobilization, community education and engagement, and psychosocial care for infected persons and their families

Number of community agents and supervisors trained in psychosocial support Number of community agents supervised (including psychosocial support)

Improve Ebola case management and infection control

Total number of staff trained on infection control http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

Strengthen non-Ebola public health activities that are impacted by the Ebola outbreak

Number of measles vaccination opportunities offered Number of local public health staff on "active" duty rosters

Increase security and logistics for local responders

Number of precincts in affected countries with ongoing transmission that have active/mobile responders (case finding, tracking, epi follow up, social mobilization, etc) Number of teams doing local work that are accompanied by a security detail Number of local site visits averted due to lack of security

Strengthen WHO emergency preparedness and response capability

Number of frontline responders trained on emerging infectious diseases Number of new or reaffirmed agreements with partners for emergency response

Outcome Measures for Short-term Outcomes:

Increased and more rapid identification of new Ebola cases in affected countries

Time elapsed from identification of possible case/contact to lab confirmation

Increased community knowledge and support for Ebola response and prevention efforts

Number of safe burials achieved % of contacts and cases having received psychosocial support

Reduced transmission in clinical and community settings

Number of cases identified

Reinvigorated non-Ebola public health activities that have been interrupted or slowed due to the Ebola outbreak

Number of measles (or other) vaccinations administered Number of persons attending measles (or other ) vaccination opportunities Number of hours/days of public health workers lost due to themselves or family members being infected with Ebola

More coordinated and robust emergency preparedness and response capabilities

Number of Foreign Medical Teams registered and ready to respond Number of Global Outbreak, Alert, and Response Network (GOARN) partners trained

ii. Applicant Evaluation and Performance Measurement Plan

Shortly after award, WHO must provide an overall evaluation and performance measurement plan that is consistent with the CDC strategy above. At a minimum, the plan must:

Describe how key program partners will participate in the evaluation and performance measurement planning processes.

Describe the type of evaluations (i.e., process, outcome, or both) to be conducted.

Describe key evaluation questions.

Describe other information (e.g., performance measures to be developed by the applicant), as determined by the CDC program, that must be included.

Describe potentially available data sources and feasibility of collecting appropriate evaluation and performance data.

Describe how evaluation findings will be used for continuous program quality improvement.

Describe how evaluation and performance measurement will contribute to developing an evidence http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf base for programs that employ strategies lacking a strong effectiveness evidence base

c. Organizational Capacity of Awardees to Execute the Approach

WHO has substantial and well-documented organizational capacity to execute global public health activities including, particularly, response to public health emergencies. WHO is fully capable of executing the activities in this FOA.

d. Work Plan

WHO must clearly identify the outcomes they expect to achieve during the project(s) and provide clear and concise descriptions of the strategies, activities, and timeline they will use to achieve the outcomes.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and awardees, site visits, and awardee reporting (including work plans, performance, and financial reporting). HHS grants policy specifies the following HHS expectations for post-award monitoring for grants and cooperative agreements:

Tracking awardee progress in achieving the desired outcomes.

Insuring the adequacy of awardee systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that awardees are performing at a sufficient level to achieve objectives within stated timeframes.

Working with awardees on adjusting the work plan based on achievement of objectives and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Other activities deemed necessary to monitor the award, if applicable.

These may include monitoring and reporting activities as outlined in HHS grants policy that assists grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk grantees.

f. CDC Program Support to Awardees

Provide consultation and technical assistance in responding to the Ebola outbreak.

Participate in evaluation of country surveillance systems or regional networks.

Participate in developing/updating surveillance guidelines for Ebola.

Provide technical assistance as requested by WHO for the response, which may include sending CDC personnel, equipment, and supplies to specific outbreak sites; providing specialized or novel reagents, and laboratory support for diagnosis of suspected infectious agents; and providing expert input on prevention and control guidelines and capacity strengthening.

Assist in epidemiologic and laboratory evaluation.

Provide technical assistance in general emergency preparedness and response.

Work with WHO to monitor and evaluate the scientific and operational accomplishments of activities.

B. Award Information http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the

CDC Program Support to Awardees Section.

2. Funding Activity Category: HL

3. Fiscal Year: 2015 Estimated Total Funding: $100,000,000

4. Approximate Total Fiscal Year Funding: $100,000,000

5. Approximate Project Period Funding: $100,000,000

6. Total Project Period Length: 3 year(s)

7. Expected Number of Awards: 1

Due to the rapid evolution of the Ebola outbreak with ever-changing needs, unique situations in each affected country, and need for rapid response and flexible support, WHO may submit 1 or more applications for projects over the term of the cooperative agreement.

There is no award ceiling or award floor for this FOA - WHO may request and CDC may approve and award funding over the term of this cooperative agreement at any amount over or under the approximate Project Period funding amount.

Pre-award costs may be requested. The applicant may include in the initial application requests for funds for emergency activities consistent with the scope of this FOA that are conducted (expenditures made) within 90 days prior to the official date of award.

8. Approximate Average Award: $100,000,000 Per Project Period

9. Award Ceiling: $0 Per Project Period

10. Award Floor: $0 Per Project Period

11. Estimated Award Date: 06/01/2015

12. Budget Period Length: 36 month(s) Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the awardee (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Funds Tracking

14. Direct Assistance Direct assistance is not available through this FOA.

15. Indirect Costs Indirect Costs are an allowable cost through this FOA.

WHO has an existing Indirect Cost Rate Agreement on file with the Department of Health and Human Services.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: Others (see text field entitled "Additional Information on Eligibility" for http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

Eligibility Category: Others (see text field entitled "Additional Information on Eligibility" for clarification)

2. Special Eligibility Requirements

Applications will only be accepted from the World Health Organization (WHO).

3. Justification for Less than Maximum Competition

WHO is the only international agency qualified to conduct the activities under this cooperative agreement because:

On September 19, 2011, the Government of the United States of America and the World Health Organization signed a memorandum of understanding (MOU) to help developing nations strengthen their capabilities to support the International Health Regulations (IHR). The IHR (2005) is an international agreement that requires WHO Member States to prevent and respond to acute public health risks that have the potential to cross borders and threaten people worldwide. The U.S.

Government and WHO share a commitment to strengthen cooperation in the area of global health security to ensure that the international community effectively manages public health risks.

Improving the ability of all nations to detect, report, and respond to infectious diseases quickly and accurately lies at the heart of the global community’s ability to address all infectious disease threats, as reflected in the IHR. The MOU establishes a framework for collaboration in line with the provisions set forth in the IHR, which provides a construct for coordinating the management of actions in the event of a public health emergency of international concern. The MOU was signed by Secretary Kathleen Sebelius, Department of Health and Human Services, and Director-General Margaret Chan, World Health Organization, and subsequently by Ambassador Betty E. King, United States Permanent Representative to the United Nations in Geneva. The full text of the MOU can be accessed at: http://www.globalhealth.gov/global-health-topics/health-diplomacy/agreements-and -regulations/20110922-mem.html.

The MOU includes the following specific statements that support sole-source consideration of WHO for funding activities that fall under the scope of the MOU: Section 8.a.: “The United States Department of Health and Human Services (DHHS) continues to serve as the primary substantive interface with WHO on global health and health security. DHHS plans to ensure coordination with other U.S. Government departments, agencies, and entities that collaborate on health matters within the scope of this Memorandum to enhance the effectiveness of such activities. The U.S. Government agencies intend to develop programs and provide funds through mechanisms that may be determined jointly by the U.S. Government agency and WHO. “Section 8.b.: “Specific funding mechanisms are intended to be developed and U.S. Government agencies intend to collaborate with WHO to define specific work to be undertaken by the Participants and the division of responsibilities.”

WHO is the lead technical agency for health within the United Nations system with 194 Member States. It is the only treaty-recognized international authority for coordinating global and regional health efforts that involve multiple countries and institutions.

WHO has a robust global infrastructure that gives it direct access to national ministries of health and other critical health institutions through its headquarters in Geneva and six regional offices (Regional Office for Africa in Brazzaville, Regional Office for Europe in Copenhagen, Regional Office for South-East Asia in New Delhi, Regional Office for the Americas in Washington, Regional Office for the Eastern Mediterranean in Cairo, and Regional Office for the Western Pacific in Manila).

WHO is the recognized global health organization to which national governments and regional health authorities look for guidance and coordination of national, regional, and global health programs. No other organization has the history, breadth of experience, existing infrastructure, and established authority among the world’s national government health agencies that would allow it to successfully carryout activities under this cooperative agreement.

http://www.globalhealth.gov/global-health-topics/health-diplomacy/agreements-and-regulations/20110922-mem.html http://www.globalhealth.gov/global-health-topics/health-diplomacy/agreements-and-regulations/20110922-mem.html http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

WHO has legal international treaty relationships with its Member States (including the United States of America) that allow supervision, coordination, collaboration, and access to multiple governments and health organizations.

WHO and its Regional Offices are at the apex of global public health organizations and thus have an exclusive status as the United States Government’s key partners for global public health.

WHO offers special opportunities for furthering global public health programs through the use of unusual talent resources, population groups, or environmental conditions in other countries that are not readily available in the United States or that augment existing U.S. resources.

4. Other

N/A

5. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

6. Maintenance of Effort

N/A

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the “Get Registered” option at http://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://www.sam.gov/portal/public/SAM/ http://grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up 1 Data Universal

Number System

(DUNS)

1. Click on http:// fedgov.dnb.com/webform

2. Select Begin DUNS search/request process

3. Select your country or territory and folllow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under DUNS number

1-2 Business Days To confirm that you have been issued a new DUNS number check online at

(http:// fedgov.dnb.com/ webform) or call 1-866-705-5711

2 System for Award Management (SAM) formerly Central Contractor Registration (CRR)

1. Retrieve organizations DUNS number

2. Go to www.sam.gov and designate an E-Biz POC (note CCR username will not not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact www.fsd.gov/US Calls: 866-606-8220

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to become an authorized organization representative (AOR)

2. Once the account is set up the

E-BIZ

POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization

Same day but can take 8 weeks to be fully registered and approved in the system (note, applicants MUST obtain a

DUNS number and SAM account before applying on grants.gov)

Register early! Log into grants.gov and check AOR status until it shows you have been approved http://www.grants.gov/ http://www.grants.gov/ http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://www.sam.gov/ http://www.fsd.gov/US http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424 application package associated with this funding opportunity from www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC PGO staff at 770-488-2700 or e-mail PGO PGOTIM@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.

4. Submission Dates and Times If the application is not submitted by the deadline published in the FOA, it will not be processed. PGO personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by PGO.

If Grants.gov cannot receive applications due to an emergency or other unanticipated event (and circumstances preclude advance notification of an extension), then applications must be submitted by the first business day on which government operations resume.

Due Date for Applications: 05/29/2015

Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.

Due to the rapid evolution of the Ebola outbreak with ever-changing needs, potential unknown needs, unique situations in each affected country, and need for rapid response and flexible support, WHO may submit 1 or more separate project proposal (e.g., by country and type of activity) over the term of this cooperative agreement project period as follows:

On the initial application due date for this FOA [insert date 30 days after publication] Quarterly for the remaining term of the coag: Due dates for quarterly submissions will be each 90-day milestone from initial award date.

For urgent emergency situations that should not be delayed until the next quarterly submission date, at anytime with prior consultation with and concurrence from CDC PGO and CDC Program Official.

This cooperative agreement will be for one 36-month budget and project period.

For each individual project proposal submitted, including any pre-award costs, WHO must include a complete:

Narrative as described in Section 10., below, Work Plan as described in Section 11., below, and Budget with narrative/justification as described in Section 12., below.

When combining multiple project proposals for any particular submission date, include a summary budget table that aggregates the requested costs for all proposals by budget line item (salary/benefits, travel, supplies, etc.).

5. CDC Assurances and Certifications All applicants are required to sign and submit CDC Assurances and Certifications documents that can be found on the CDC Web site: http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html

Applicants may follow either of the following processes:

Applicants must name this file "Assurances and Certifications" and upload as a PDF on www.grants.gov.

http://www.grants.gov http://www.grants.gov/ http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf www.grants.gov.

Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http:// www.cdc.gov/od/pgo/ funding/grants/ foamain.shtm

Assurances and certifications submitted directly to CDC will be kept on file for 1 year and will apply to all applications submitted to CDC within one year of the submission date.

6. Contents and Form of Applications Submission Applicants are required to submit all of the documents outlined below as their application package on www.grants.gov.

7. Letter of Intent (LOI)

LOI is not requested or required as part of the application for this FOA.

8. Table of Contents (No page limit, not included in project narrative page limit). Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary (Maximum of 1 page, single spaced, 12 point font, 1-inch margins). A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov. The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the “Project Abstract Summary” text box at www.grants.gov.

10. Project Narrative (Maximum of 18 pages single spaced, Calibri 12 point, 1-inch margins, number all pages, content beyond 18 pages will not be reviewed). The Project Narrative must include all of the bolded headings shown in this section. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to be conducted over the entire project period as identified in the CDC Project Description section.

Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov.

a. Background Applicants should provide a description of relevant background information that includes the context of the problem (see CDC Background).

b. Approach

i. Problem Statement Applicants must describe the core information relative to the problem for the jurisdictions or populations they serve. The core information should help reviewers understand how the applicant’s response to the FOA will address the public health problem and support public health priorities. (See CDC Project Description).

ii. Purpose Applicants must describe specifically how their application will address the problem as described in the CDC Project Description.

http://www.grants.gov/ http://www.cdc.gov/od/pgo/funding/grants/foamain.shtm http://www.grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

iii. Outcomes Applicants must clearly identify the outcomes they expect to achieve by the end of the project period.

Outcomes are the results that the program intends to achieve. All outcomes should indicate the intended direction of change (i.e., increase, decrease, maintain). See the program logic model in the Approach section of the CDC Project Description.

iv. Strategy and Activities The applicant must provide a clear and concise description of the strategies and activities they will use to achieve the project period outcomes. Whenever possible, applicants should use evidence-based program strategies as identified by the Community Guide (or similar reviews) and reference it explicitly as a source.

Applicants may propose additional strategies and activities to achieve the outcomes. Applicants should select existing evidence-based strategies that meet their needs, or describe the rationale for developing and evaluating new strategies or practice-based innovations. (See CDC Project description: Strategies and Activities section).

c. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that is consistent with the CDC Evaluation and Performance Measurement Strategy section of the CDC Project Description of this FOA.

Data collected must be used for ongoing monitoring of the award to evaluate its effectiveness, and for continuous program improvement.

The plan must:

Describe how key program partners will be engaged in the evaluation and performance measurement planning processes.

Describe the type of evaluations to be conducted (i.e. process and/or outcome).

Describe key evaluation questions to be answered.

Describe other information, as determined by the CDC program (e.g., performance measures to be developed by the applicant) that should be included.

Describe potentially available data sources and feasibility of collecting appropriate evaluation and performance data.

Describe how evaluation findings will be used for continuous program and quality improvement.

Describe how evaluation and performance measurement will contribute to development of that evidence base, where program strategies are being employed that lack a strong evidence base of effectiveness.

Awardees will be required to submit a more detailed evaluation and performance measurement plan within the first 6 months of the project, as outlined in the reporting section of the FOA.

Awardees will be required to submit a more detailed evaluation and performance measurement plan within the first six months of the project, as outlined in the reporting section of the FOA.

d. Organizational Capacity of Applicants to Implement the Approach Applicant must address the organizational capacity requirements as described in the CDC Project Description.

11. Work Plan http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

11. Work Plan Applicants must prepare a work plan consistent with the CDC Project Description Work Plan section. The work plan integrates and delineates more specifically how the awardee plans to carry out achieving the project period outcomes, strategies, and activities, evaluation and performance measurement, including key milestones.

Applicants must name this file “Work Plan” and upload it as a PDF file at www.grants.gov.

12. Budget Narrative Applicants must submit an itemized budget narrative, which may be scored as part of the Organizational Capacity of Awardees to Execute the Approach. When developing the budget narrative, applicants must consider whether the proposed budget is reasonable and consistent with the purpose, outcomes, and program strategy outlined in the project narrative. The budget must include:

Salaries and wages Fringe benefits Consultant costs Equipment Supplies Travel Alterations and Renovations Other categories Contractual costs Total Direct costs Total Indirect costs

For guidance on completing a detailed budget, see Budget Preparation Guidelines at:

http://www.cdc.gov/grants/interestedinapplying/applicationresources.html

Applicants should name this file “Budget Narrative” and upload it as a PDF file to www.grants.gov. If requesting indirect costs in the budget, a copy of the indirect cost rate agreement is required. If the indirect cost rate is a provisional rate, the agreement must have been made less than 12 months earlier. Applicants must name this file “Indirect Cost Rate” and upload it to www.grants.gov.

Budget narratives must include all details and line-item justification for all costs proposed, including any pre-award costs.

13. Tobacco and Nutrition Policies Awardees are encouraged to implement tobacco and nutrition policies.

Unless otherwise explicitly permitted under the terms of a specific CDC award, no funds associated with this FOA may be used to implement the optional policies, and no applicants will be evaluated or scored on whether they choose to implement these optional policies.

CDC supports implementing evidence-based programs and policies to reduce tobacco use and secondhand smoke exposure, and to promote healthy nutrition. CDC encourages all awardees to implement the following optional recommended evidence-based tobacco and nutrition policies within their own organizations. The tobacco policies build upon the current federal commitment to reduce exposure to secondhand smoke, specifically The Pro-Children Act, 20 U.S.C. 7181-7184, that prohibits smoking in certain facilities that receive federal funds in which education, library, day care, health care,or early childhood development services are provided to children.

Tobacco Policies:

Tobacco-free indoors: Use of any tobacco products (including smokeless tobacco) or electronic cigarettes is not allowed in any indoor facilities under the control of the awardee.

1.

http://www.grants.gov http://www.cdc.gov/grants/interestedinapplying/applicationresources.html http://www.grants.gov http://www.grants.gov http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf cigarettes is not allowed in any indoor facilities under the control of the awardee.

Tobacco-free indoors and in adjacent outdoor areas: Use of any tobacco products or electronic cigarettes is not allowed in any indoor facilities, within 50 feet of doorways and air intake ducts, and in courtyards under the control of the awardee.

2.

Tobacco-free campus: Use of any tobacco products or electronic cigarettes is not allowed in any indoor facilities or anywhere on grounds or in outdoor space under the control of the awardee.

3.

Nutrition Policies:

Healthy food-service guidelines must, at a minimum, align with HHS and General Services Administration Health and Sustainability Guidelines for Federal Concessions and Vending Operations.

These guidelines apply to cafeterias, snack bars, and vending machines in any facility under the control of the awardee and in accordance with contractual obligations for these services (see: http://www.gsa.gov/ graphics/pbs/Guidelines_for_ Federal_ Concessions_and_Vending _ Operations.pdf).

1.

Resources that provide guidance for healthy eating and tobacco-free workplaces are:2.

http://www.cdc.gov/ nccdphp/dnpao/hwi/ toolkits/ tobacco/index.htm http://www. thecommunityguide.org/ tobacco/index.html http://www.cdc.gov/ chronicdisease/resources/ guidelines/food-service-guidelines.htm

14. Intergovernmental Review

Executive Order 12372 does not apply to this program.

15. Funding Restrictions Restrictions that must be considered while planning the programs and writing the budget are:

Awardees may not use funds for research.

Awardees may not use funds for clinical care except as allowed by law.

Awardees may only use funds for reasonable program purposes, including personnel, travel, supplies, and services (such as contractual).

Generally, awardees may not use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be clearly identified in the budget in accordance with CDC’s budget guidelines.

Reimbursement of pre-award costs is not allowed.

Other than for normal and recognized executive-legislative relationships, no funds may be used for:

Publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body The salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC awardees.

The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project outcomes and not merely serve as a conduit for an award to another party or provider who is ineligible.

16. Other Submission Requirements http://www.gsa.gov/ graphics/pbs/Guidelines_for_ Federal_ Concessions_and_Vending _ Operations.pdf http://www.gsa.gov/ graphics/pbs/Guidelines_for_ Federal_ Concessions_and_Vending _ Operations.pdf http://www.cdc.gov/nccdphp/dnpao/hwi/toolkits/tobacco/index.htm http:// www.thecommunityguide.org/ tobacco/index.html http://www.cdc.gov/…